Wells Fargo’s Nutraceutical International Co NUTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-6,046
| Closed | -$252K | – | 6653 |
|
|
2017
Q2 | $252K | Buy |
6,046
+124
| +2% | +$4.42K | ﹤0.01% | 4644 |
|
|
2017
Q1 | $184K | Hold |
5,922
| – | – | ﹤0.01% | 4870 |
|
|
2016
Q4 | $207K | Buy |
5,922
+2,161
| +57% | +$68.5K | ﹤0.01% | 4754 |
|
|
2016
Q3 | $117K | Hold |
3,761
| – | – | ﹤0.01% | 4821 |
|
|
2016
Q2 | $87K | Sell |
3,761
-5,322
| -59% | -$127K | ﹤0.01% | 4915 |
|
|
2016
Q1 | $222K | Buy |
9,083
+6,429
| +242% | +$156K | ﹤0.01% | 4345 |
|
|
2015
Q4 | $68K | Buy |
2,654
+919
| +53% | +$22.6K | ﹤0.01% | 5156 |
|
|
2015
Q3 | $41K | Sell |
1,735
-85
| -5% | -$2.03K | ﹤0.01% | 5331 |
|
|
2015
Q2 | $45K | Buy |
1,820
+1,369
| +304% | +$28.9K | ﹤0.01% | 5358 |
|
|
2015
Q1 | $9K | Buy |
451
+50
| +12% | +$941 | ﹤0.01% | 5677 |
|
|
2014
Q4 | $9K | Buy |
401
+3
| +0.8% | +$65 | ﹤0.01% | 5699 |
|
|
2014
Q3 | $8K | Sell |
398
-280
| -41% | -$6.52K | ﹤0.01% | 5698 |
|
|
2014
Q2 | $16K | Buy |
+678
| New | +$16.6K | ﹤0.01% | 5481 |
|
Wells Fargo's NUTR Position: Q3 2017 in Review
Wells Fargo sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 6,046 shares — an estimated $252K sold.
Wells Fargo first reported a position in NUTR in Q2 2014 and held it in 13 quarters. The position peaked at $252K in Q2 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.
- Wells Fargo reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
- Wells Fargo sold 6,046 Nutraceutical International Co shares in Q3 2017, an estimated $252K.
- Wells Fargo first reported a position in Nutraceutical International Co in Q2 2014 and held it in 13 quarters.
- Wells Fargo's Nutraceutical International Co position peaked at $252K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.
Based on Wells Fargo's 13F filing for Q3 2017, filed 9 Nov 2017.